Skip to content
Disclosery

Deep Track Capital, LP

Follow

13F filer, CIK 1856083, GREENWICH, CT

Deep Track Capital, LP reported $5,608,747,587 across 55 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-13. Its ten largest share positions make up 53.15% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001856083-26-000001

Period
2025-12-31
Reported value
$5.61B
Holdings
55
Top 10 weight
53.15%
New
17
Sold out
18

Largest buys vs the previous quarter

SecurityShares changeApprox. value
VERAnew+2,821,135$143M
BMRNadded+2,275,144$135M
GRALnew+1,022,797$87.5M
MLTXnew+4,610,071$60.8M
ALKSnew+2,000,000$56M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TERNreduced-6,725,952-$272M
AKROexited-4,000,978-$190M
IONSreduced-2,108,144-$167M
GHreduced-1,354,086-$138M
89BIO INCexited-9,356,171-$138M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001856083-26-000001, largest first. % of portfolio is the value over $4,383,802,587, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,347,464 shares; 2024Q4: 6,000,000 shares; 2025Q1: 9,500,000 shares; 2025Q2: 9,500,000 shares; 2025Q3: 9,728,845 shares; 2025Q4: 11,526,971 shares 11,526,971$293M6.68%+1,798,126Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 6,000,560 shares; 2024Q4: 6,419,566 shares; 2025Q1: 5,443,721 shares; 2025Q2: 4,250,000 shares; 2025Q3: 4,154,086 shares; 2025Q4: 2,800,000 shares 2,800,000$286M6.52%-1,354,086Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,220,508 shares; 2024Q4: 2,800,000 shares; 2025Q1: 4,100,000 shares; 2025Q2: 5,133,917 shares; 2025Q3: 4,215,811 shares; 2025Q4: 4,111,782 shares 4,111,782$286M6.52%-104,029Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,484,266 shares; 2025Q2: 1,750,000 shares; 2025Q3: 3,000,000 shares; 2025Q4: 3,004,034 shares 3,004,034$246M5.61%+4,034Timeline
DVAXDYNAVAX TECHNOLOGIES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 12,526,486 shares; 2024Q4: 17,791,486 shares; 2025Q1: 17,791,486 shares; 2025Q2: 17,791,486 shares; 2025Q3: 15,726,349 shares; 2025Q4: 15,726,349 shares 15,726,349$242M5.52%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 629,906 shares; 2024Q4: 2,500,000 shares; 2025Q1: 3,073,853 shares; 2025Q2: 3,650,000 shares; 2025Q3: 4,300,000 shares; 2025Q4: 3,336,998 shares 3,336,998$212M4.84%-963,002Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 857,219 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 801,371 shares; 2025Q3: 900,000 shares; 2025Q4: 1,150,000 shares 1,150,000$210M4.79%+250,000Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,400,654 shares; 2024Q4: 4,274,921 shares; 2025Q1: 5,000,000 shares; 2025Q2: 7,000,000 shares; 2025Q3: 8,000,382 shares; 2025Q4: 7,750,000 shares 7,750,000$195M4.44%-250,382Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 750,000 shares; 2025Q2: 2,150,000 shares; 2025Q3: 3,000,000 shares; 2025Q4: 4,000,000 shares 4,000,000$185M4.21%+1,000,000Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,269,126 shares; 2025Q2: 3,948,910 shares; 2025Q3: 3,948,910 shares; 2025Q4: 4,246,440 shares 4,246,440$176M4.01%+297,530Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,821,135 shares 2,821,135$143M3.26%newTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 24,856 shares; 2025Q4: 2,300,000 shares 2,300,000$137M3.12%+2,275,144Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,200,000 shares; 2024Q4: 1,933,928 shares; 2025Q1: 4,564,207 shares; 2025Q2: 4,891,544 shares; 2025Q3: 3,808,144 shares; 2025Q4: 1,700,000 shares 1,700,000$134M3.07%-2,108,144Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,868,104 shares; 2024Q4: 3,000,000 shares; 2025Q1: 5,500,000 shares; 2025Q2: 6,064,910 shares; 2025Q3: 6,057,024 shares; 2025Q4: 7,036,455 shares 7,036,455$133M3.04%+979,431Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,018,935 shares; 2024Q4: 3,018,935 shares; 2025Q1: 3,018,935 shares; 2025Q2: 2,188,592 shares; 2025Q3: 3,150,000 shares; 2025Q4: 3,249,790 shares 3,249,790$102M2.34%+99,790Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 12,721,460 shares; 2024Q4: 12,836,282 shares; 2025Q1: 14,294,420 shares; 2025Q2: 14,294,420 shares; 2025Q3: 11,932,137 shares; 2025Q4: 8,070,414 shares 8,070,414$98M2.23%-3,861,723Timeline
GRALGRAIL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,022,797 shares 1,022,797$87.5M2%newTimeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,750,945 shares; 2024Q4: 4,522,741 shares; 2025Q1: 5,380,449 shares; 2025Q2: 5,380,449 shares; 2025Q3: 5,380,449 shares; 2025Q4: 2,524,833 shares 2,524,833$78.6M1.79%-2,855,616Timeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,352,804 shares; 2025Q4: 3,352,804 shares 3,352,804$74.6M1.7%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 519,376 shares; 2025Q1: 1,411,402 shares; 2025Q2: 1,800,000 shares; 2025Q3: 1,800,000 shares; 2025Q4: 2,003,978 shares 2,003,978$69.6M1.59%+203,978Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,235,187 shares; 2024Q4: 750,000 shares; 2025Q1: 1,444,709 shares; 2025Q2: 1,918,798 shares; 2025Q3: 2,654,781 shares; 2025Q4: 2,161,510 shares 2,161,510$65.5M1.49%-493,271Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 819,162 shares; 2025Q1: 2,800,000 shares; 2025Q2: 900,000 shares; 2025Q3: 1,200,000 shares; 2025Q4: 810,142 shares 810,142$62M1.41%-389,858Timeline
CRMDCORMEDIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 500,000 shares; 2025Q4: 5,274,076 shares 5,274,076$61.3M1.4%+4,774,076Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,610,071 shares 4,610,071$60.8M1.39%newTimeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,500,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,000,000 shares 2,000,000$56M1.28%newTimeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,282,000 shares; 2024Q4: 2,000,000 shares; 2025Q1: 2,000,000 shares; 2025Q2: not reported; 2025Q3: 2,000,000 shares; 2025Q4: 2,650,000 shares 2,650,000$51.8M1.18%+650,000Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,540,132 shares; 2025Q1: 2,000,000 shares; 2025Q2: 2,000,000 shares; 2025Q3: 2,000,000 shares; 2025Q4: 1,900,738 shares 1,900,738$51.6M1.18%-99,262Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 8,859,648 shares; 2025Q2: 8,831,007 shares; 2025Q3: 7,859,648 shares; 2025Q4: 7,334,323 shares 7,334,323$50.6M1.15%-525,325Timeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,350,000 shares; 2024Q4: 1,350,000 shares; 2025Q1: not reported; 2025Q2: 500,000 shares; 2025Q3: not reported; 2025Q4: 2,000,000 shares 2,000,000$50M1.14%newTimeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,000,000 shares 1,000,000$46.3M1.06%newTimeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,740,850 shares 5,740,850$44.3M1.01%newTimeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 796,852 shares; 2024Q4: 2,000,000 shares; 2025Q1: 2,000,000 shares; 2025Q2: 2,426,657 shares; 2025Q3: 2,426,657 shares; 2025Q4: 2,614,004 shares 2,614,004$44M1%+187,347Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,575,049 shares; 2024Q4: 4,011,287 shares; 2025Q1: 38,176,251 shares; 2025Q2: 43,000,000 shares; 2025Q3: 41,096,522 shares; 2025Q4: 32,511,271 shares 32,511,271$42.9M0.98%-8,585,251Timeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,607,633 shares; 2024Q4: 4,557,575 shares; 2025Q1: 4,557,575 shares; 2025Q2: 4,557,575 shares; 2025Q3: 2,239,353 shares; 2025Q4: 4,377,572 shares 4,377,572$39.5M0.9%+2,138,219Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 504,828 shares; 2024Q4: 649,042 shares; 2025Q1: 700,000 shares; 2025Q2: 700,000 shares; 2025Q3: 450,000 shares; 2025Q4: 477,684 shares 477,684$37.7M0.86%+27,684Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,576,558 shares; 2024Q4: 5,576,558 shares; 2025Q1: 5,576,558 shares; 2025Q2: 7,495,000 shares; 2025Q3: 7,495,000 shares; 2025Q4: 769,048 shares 769,048$31.1M0.71%-6,725,952Timeline
ENTAENANTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,956,867 shares 1,956,867$30.9M0.7%newTimeline
MIND MEDICINE MINDMED INCMIND MEDICINE MINDMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,065,099 shares; 2024Q4: 2,816,594 shares; 2025Q1: 2,500,000 shares; 2025Q2: 2,500,000 shares; 2025Q3: 1,500,000 shares; 2025Q4: 1,676,540 shares 1,676,540$22.4M0.51%+176,540
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,454,562 shares; 2025Q4: 2,454,562 shares 2,454,562$21.7M0.5%+1,000,000Timeline
XFORX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,122,484 shares; 2025Q4: 5,013,661 shares 5,013,661$20.1M0.46%+3,891,177Timeline
ATAIBECKLEY INCATAIBECKLEY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,677,289 shares 4,677,289$19.1M0.44%new
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 169,132 shares; 2025Q1: 1,000,000 shares; 2025Q2: 1,350,000 shares; 2025Q3: 1,200,000 shares; 2025Q4: 366,435 shares 366,435$16.4M0.37%-833,565Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 453,102 shares 453,102$16.1M0.37%newTimeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,529,987 shares; 2024Q4: 1,529,987 shares; 2025Q1: 1,529,987 shares; 2025Q2: 1,529,987 shares; 2025Q3: 1,000,000 shares; 2025Q4: 1,854,255 shares 1,854,255$15.2M0.35%+854,255Timeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,419,355 shares; 2024Q4: 7,419,355 shares; 2025Q1: 7,419,355 shares; 2025Q2: 7,419,355 shares; 2025Q3: 7,419,355 shares; 2025Q4: 7,419,355 shares 7,419,355$10.9M0.25%0Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 95,408 shares 95,408$6.23M0.14%newTimeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 453,686 shares; 2025Q3: 453,686 shares; 2025Q4: 453,686 shares 453,686$5.38M0.12%0Timeline
ALGSALIGOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 244,110 shares; 2024Q4: 244,110 shares; 2025Q1: 444,110 shares; 2025Q2: 444,110 shares; 2025Q3: 444,110 shares; 2025Q4: 444,110 shares 444,110$4.14M0.09%0Timeline
BLLNBILLIONTOONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,000 shares 50,000$4.09M0.09%newTimeline
RAPTRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 751,422 shares; 2025Q3: 751,422 shares; 2025Q4: 110,448 shares 110,448$3.74M0.09%-640,974Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 490,000 shares 490,000$2.28M0.05%newTimeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 89,589 shares 89,589$1.24M0.03%newTimeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 34,852 shares 34,852$49.5K<0.01%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
XBISPDR SERIES TRUST S&P BIOTECHput10,000,000$1.22Bnew
BHVNBIOHAVEN LTD COMcall500,000$5.64Mnew

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AKROAKERO THERAPEUTICS INC4,000,978$190Mshares
89BIO INC89BIO INC9,356,171$138Mshares
PTGXPROTAGONIST THERAPEUTICS INC1,715,691$114Mshares
EXASEXACT SCIENCES CORP1,000,000$54.7Mshares
OLMAOLEMA PHARMACEUTICALS INC3,470,172$34Mshares
CDTXCIDARA THERAPEUTICS INC300,000$28.7Mshares
QUREUNIQURE NV483,092$28.2Mshares
JBIOJADE BIOSCIENCES INC2,279,892$19.7Mshares
GHRSGH RESEARCH PLC1,250,000$17.9Mshares
GMABGENMAB A/S481,267$14.8Mshares
IMAIMAGENEBIO INC878,516$7.16Mshares
XNCRXENCOR INC549,439$6.44Mshares
PEPGPEPGEN INC1,200,000$5.54Mshares
AUTLAUTOLUS THERAPEUTICS LTD2,568,613$4.19Mshares
ACADACADIA PHARMACEUTICALS INC105,085$2.24Mshares
AVTXAVALO THERAPEUTICS INC144,600$1.84Mshares
ZURAZURA BIO LTD259,014$1.12Mshares
CLYMCLIMB BIO INC509,789$1.02Mshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001856083-26-000001 base2026-02-13acceptance time not in the bulk data set